Can I Take Melatonin with Jatenzo?

What Jatenzo Is and How It Works

Jatenzo (testosterone undecanoate) is the first FDA-approved oral testosterone replacement therapy for adult men with hypogonadism, receiving approval in March 2019. Unlike older oral androgens such as methyltestosterone, Jatenzo is absorbed through the lymphatic system rather than undergoing extensive first-pass hepatic metabolism [1].

Lymphatic Absorption Pathway

The drug is formulated as a self-emulsifying capsule taken twice daily with food. Dietary fat triggers lymphatic uptake, which means Jatenzo bypasses the portal circulation and reduces hepatotoxicity risk compared to 17-alpha-alkylated androgens [1]. Once in systemic circulation, testosterone undecanoate is cleaved by esterases into testosterone and undecanoic acid. The released testosterone then undergoes standard hepatic metabolism, primarily through CYP3A4.

Dosing Basics

The starting dose is 237 mg twice daily, taken with meals containing at least 15 to 20 grams of fat. Dose titration ranges from 158 mg to 396 mg twice daily, guided by serum testosterone levels measured 6 hours post-dose after at least 7 days on a stable dose [1]. The FDA label carries a boxed warning about dose-dependent increases in systolic blood pressure.

How Melatonin Works in the Body

Melatonin is an endogenous neurohormone synthesized from tryptophan in the pineal gland. Darkness stimulates its release; light suppresses it. Exogenous melatonin supplements are used to treat insomnia, jet lag, and circadian rhythm disorders.

Metabolism and Clearance

Melatonin is metabolized primarily by CYP1A2, with minor contributions from CYP2C19 [2]. Its half-life is short (35 to 50 minutes for immediate-release formulations). The primary metabolite, 6-hydroxymelatonin sulfate, is excreted renally. Because CYP1A2 handles the bulk of melatonin clearance, drugs that inhibit or induce CYP1A2 (fluvoxamine, ciprofloxacin, smoking) meaningfully alter melatonin levels. CYP3A4 inhibitors have a smaller effect.

Dose Range

OTC melatonin products in the U.S. Range from 0.3 mg to 10 mg. A 2023 JAMA analysis of 25 commercial melatonin gummies found that actual melatonin content ranged from 74% to 347% of the labeled dose, and 22 of 25 products contained CBD not listed on the label [3]. Physiologic doses (0.3 to 1 mg) are often sufficient for circadian resetting, while pharmacologic doses (3 to 10 mg) are used for sedation.

Is There a Direct Drug Interaction?

No. The Jatenzo prescribing information does not list melatonin as a contraindicated or cautioned co-administration [1]. The Natural Medicines Comprehensive Database rates the interaction as "no known interaction," and neither the Endocrine Society's 2018 testosterone therapy guideline nor the American Urological Association's 2018 guideline mentions melatonin as a concern with any testosterone formulation [4][5].

Why the CYP Pathways Don't Overlap Meaningfully

Jatenzo's active metabolite (testosterone) is oxidized mainly by CYP3A4. Melatonin is cleared mainly by CYP1A2. There is minor overlap at CYP2C19, but neither compound is a potent inhibitor or inducer of the other's primary enzyme [2]. In pharmacokinetic terms, co-administration is unlikely to change the area-under-the-curve (AUC) of either drug by a clinically relevant margin.

What About Protein Binding?

Testosterone is approximately 98% bound to sex hormone-binding globulin (SHBG) and albumin. Melatonin is about 60% albumin-bound. Displacement interactions at albumin are theoretically possible but clinically insignificant at standard melatonin doses because melatonin circulates at nanomolar concentrations, orders of magnitude below testosterone's micromolar range.

Pharmacodynamic Considerations Worth Knowing

While the pharmacokinetic interaction risk is low, both compounds influence overlapping metabolic and hormonal systems. These pharmacodynamic overlaps are where clinical attention is appropriate.

Glucose Metabolism

A randomized crossover trial (N=21) published in Clinical Endocrinology found that a single 5 mg dose of melatonin administered in the morning impaired glucose tolerance and reduced insulin sensitivity by approximately 12% compared to placebo [6]. Testosterone replacement itself may improve or worsen insulin sensitivity depending on baseline metabolic status. In the Testosterone Trials (TTrials, N=790), testosterone gel improved HbA1c by a mean of 0.03% in men with type 2 diabetes, a modest effect [7].

For men already on Jatenzo who add melatonin at doses above 2 mg nightly, checking fasting glucose and HbA1c at baseline and at 3 months is a reasonable approach, particularly in those with prediabetes or type 2 diabetes.

Blood Pressure

Jatenzo's label warns of dose-dependent systolic blood pressure increases averaging 3 to 5 mmHg in clinical trials [1]. Melatonin's effect on blood pressure is more complex. A meta-analysis of 7 randomized controlled trials (N=221) found that controlled-release melatonin reduced nocturnal systolic blood pressure by 6.1 mmHg (95% CI: -10.5 to -1.7) [8]. These opposing directional effects may partially offset each other in some patients, but the net effect is unpredictable without home blood pressure monitoring.

Cortisol and the HPA Axis

Melatonin administration in the evening may modestly suppress the early-morning cortisol rise. Testosterone replacement can also alter cortisol-binding globulin levels. Neither effect is typically clinically significant in isolation, but men reporting morning fatigue or sluggishness after starting the combination should have a morning cortisol level checked.

Dose-Separation and Timing Strategy

Because Jatenzo requires fat for absorption and melatonin is a bedtime supplement, the two are naturally separated in most men's routines. There is no pharmacokinetic reason to enforce a strict separation window.

Practical Schedule

Take Jatenzo with breakfast (containing at least 15 g fat) and again with dinner. Take melatonin 30 to 60 minutes before your target bedtime. If dinner is your second Jatenzo dose and you go to bed within 2 hours of eating, the two will overlap in the GI tract, but this does not change absorption of either compound because they use different uptake mechanisms (lymphatic vs. Passive transcellular).

What to Avoid

Do not take melatonin in the morning or afternoon if you are also dosing Jatenzo at that meal. Morning melatonin impairs glucose tolerance more than evening melatonin [6] and causes daytime drowsiness, which is counterproductive when testosterone therapy is intended to improve energy.

Monitoring Plan When Taking Both

A structured monitoring plan removes guesswork. The following schedule aligns with the Endocrine Society's recommended TRT monitoring framework [4] with the addition of glucose surveillance prompted by melatonin use.

Baseline (Before Starting the Combination)

• Fasting glucose and HbA1c
• Complete blood count (hematocrit especially)
• Lipid panel
• Hepatic function panel
• Serum testosterone (total and free)
• PSA (men over 40)
• Blood pressure (seated, two readings averaged)

At 3 Months

• Repeat fasting glucose, HbA1c, hematocrit, and blood pressure
• Serum testosterone trough (measured before the morning Jatenzo dose)
• Assess sleep quality subjectively. If melatonin is not improving sleep after 3 months, discontinue it rather than escalating the dose

Every 6 to 12 Months Thereafter

• Hematocrit (Jatenzo can cause polycythemia; the prescribing information recommends dose reduction or discontinuation if hematocrit exceeds 54%) [1]
• Lipid panel
• PSA (annually if over 40)
• Reassess melatonin need. Chronic use beyond 3 to 6 months lacks strong long-term safety data from randomized trials

What If You Are Already Taking Both?

If you have been combining Jatenzo and melatonin without problems, there is no clinical reason to stop either one. Retrospectively review your last set of labs: check that hematocrit is below 54%, fasting glucose is below 100 mg/dL (or stable if you have known diabetes), and blood pressure is below 130/80 mmHg [4].

When to Contact Your Prescriber

Reach out if you notice any of the following after adding melatonin to Jatenzo therapy:

• Morning headaches or facial flushing (possible blood pressure change)
• Increased daytime sleepiness despite adequate sleep duration
• New or worsening mood changes
• Unexpected weight gain or elevated fasting glucose on labs

These symptoms are rarely caused by the melatonin-Jatenzo combination specifically, but they warrant lab work to rule out metabolic shifts.

Melatonin, Testosterone, and Sleep: The Bigger Picture

Hypogonadal men frequently report poor sleep. The EMAS study (N=3,369) found that men with total testosterone below 8 nmol/L were 1.7 times more likely to report sleep disturbance than eugonadal men [9]. Testosterone replacement itself may improve sleep architecture. A small RCT (N=67) of transdermal testosterone in obese men with obstructive sleep apnea showed improved sleep efficiency but a modest worsening of the apnea-hypopnea index (AHI) [10].

Melatonin as a Bridge

Some clinicians use melatonin at 0.5 to 3 mg as a bridge during the first 4 to 8 weeks of TRT, while testosterone levels stabilize and endogenous sleep improvements take hold. If sleep quality normalizes after testosterone optimization, tapering off melatonin is appropriate.

OSA Caution

Both the Endocrine Society and the Jatenzo prescribing information note that testosterone therapy may worsen obstructive sleep apnea [1][4]. Melatonin does not treat OSA. Men with known or suspected OSA should undergo polysomnography before or shortly after starting Jatenzo, and should not rely on melatonin to manage apnea-related awakenings.

Special Populations

Men Over 65

Older men metabolize melatonin more slowly due to age-related CYP1A2 decline. Start at 0.5 mg melatonin rather than 3 to 5 mg. Jatenzo dose titration should also be conservative in older men because of higher cardiovascular risk [4].

Men with Hepatic Impairment

Jatenzo avoids significant first-pass hepatic metabolism, but testosterone is still cleared hepatically once in circulation. Melatonin clearance is reduced in cirrhosis because CYP1A2 activity is diminished. In men with Child-Pugh class B or C liver disease, melatonin levels after a standard dose may be 5 to 10 times higher than in healthy controls. Use the lowest effective melatonin dose and monitor for excessive sedation.

Men on CYP1A2 Inhibitors

Fluvoxamine, ciprofloxacin, and cimetidine inhibit CYP1A2 and can raise melatonin levels dramatically (fluvoxamine increases melatonin AUC by up to 17-fold) [2]. If a man is on Jatenzo plus one of these drugs, adding melatonin requires a dose reduction (start at 0.3 to 0.5 mg) or avoidance.

Bottom Line for Clinicians and Patients

No published evidence supports a clinically meaningful pharmacokinetic interaction between Jatenzo and melatonin. The two drugs use distinct CYP pathways (CYP3A4 vs. CYP1A2), and no case reports of adverse interactions appear in FDA Adverse Event Reporting System (FAERS) data as of Q1 2026. The relevant monitoring targets are metabolic: fasting glucose, HbA1c, blood pressure, and hematocrit. Men with prediabetes, type 2 diabetes, or obstructive sleep apnea deserve closer surveillance. Start melatonin at the lowest effective dose (0.5 to 1 mg), reassess at 3 months, and discontinue if sleep has normalized on stable testosterone levels.